Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
25.92
-0.41 (-1.56%)
May 28, 2025, 4:00 PM - Market closed
Harrow Market Cap
Harrow has a market cap or net worth of $951.25 million as of May 29, 2025. Its market cap has increased by 131.90% in one year.
Market Cap
951.25M
Enterprise Value
1.11B
1-Year Change
131.90%
Ranking
Category
Stock Price
$25.92
Market Cap Chart
Since March 31, 2009, Harrow's market cap has increased from $14.00M to $951.25M, an increase of 6,694.66%. That is a compound annual growth rate of 29.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 28, 2025 | 951.30M | -20.39% |
Dec 31, 2024 | 1.19B | 203.81% |
Dec 29, 2023 | 393.30M | -2.79% |
Dec 30, 2022 | 404.60M | 74.10% |
Dec 31, 2021 | 232.40M | 31.60% |
Dec 31, 2020 | 176.60M | -9.81% |
Dec 31, 2019 | 195.80M | 47.77% |
Dec 31, 2018 | 132.50M | 279.66% |
Dec 29, 2017 | 34.90M | 5.44% |
Dec 30, 2016 | 33.10M | -50.67% |
Dec 31, 2015 | 67.10M | -3.31% |
Dec 31, 2014 | 69.40M | 130.56% |
Dec 31, 2013 | 30.10M | -53.19% |
Dec 31, 2012 | 64.30M | 3,284.21% |
Dec 30, 2011 | 1.90M | -85.04% |
Dec 31, 2010 | 12.70M | -45.96% |
Dec 31, 2009 | 23.50M | 67.86% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.66B |
Johnson & Johnson | 366.95B |
AbbVie | 327.10B |
Novo Nordisk | 313.75B |
UnitedHealth Group | 265.57B |
Abbott Laboratories | 231.05B |
Novartis AG | 224.07B |
AstraZeneca | 219.48B |